Cargando…

The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction

OBJECTIVE: To investigate and to quantify the relationship between hospital costs and health outcomes for patients with acute myocardial infarction (AMI) in Veterans Health Administration (VHA) hospitals using individual-level data for costs and outcomes. DATA SOURCES: VHA administrative files for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreyögg, Jonas, Stargardt, Tom
Formato: Texto
Lenguaje:English
Publicado: Blackwell Science Inc 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997322/
https://www.ncbi.nlm.nih.gov/pubmed/20819109
http://dx.doi.org/10.1111/j.1475-6773.2010.01161.x
_version_ 1782193292393316352
author Schreyögg, Jonas
Stargardt, Tom
author_facet Schreyögg, Jonas
Stargardt, Tom
author_sort Schreyögg, Jonas
collection PubMed
description OBJECTIVE: To investigate and to quantify the relationship between hospital costs and health outcomes for patients with acute myocardial infarction (AMI) in Veterans Health Administration (VHA) hospitals using individual-level data for costs and outcomes. DATA SOURCES: VHA administrative files for the fiscal years 2000–2006. STUDY DESIGN: Costs were defined as costs incurred during the index hospitalization for treatment of AMI. Mortality and readmission, assessed 1 year after the index hospitalization, were used as measures of clinical outcome. We examined health outcomes as a function of costs and other patient-level and hospital-level characteristics using a two-stage Cox proportional hazard model that accounted for competing risks within a multilevel framework. To control for patient comorbidities, we compiled a comprehensive list of comorbidities that have been found in other studies to affect mortality and readmissions. PRINCIPAL FINDINGS: We found that costs were negatively associated with mortality and readmissions. Every U.S.$100 less spent is associated with a 0.63 percent increase in the hazard of dying and a 1.24 percent increase in the hazard to be readmitted conditional on not dying. This main finding remained unchanged after a number of sensitivity checks. CONCLUSIONS: Our results suggest that there is a trade-off between costs and outcomes. The negative association between costs and mortality suggests that outcomes should be monitored closely when introducing cost-containment programs. Additional studies are needed to examine the cost–outcome relationship for conditions other than AMI to see whether our results are consistent.
format Text
id pubmed-2997322
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Science Inc
record_format MEDLINE/PubMed
spelling pubmed-29973222010-12-29 The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction Schreyögg, Jonas Stargardt, Tom Health Serv Res Quality of Care OBJECTIVE: To investigate and to quantify the relationship between hospital costs and health outcomes for patients with acute myocardial infarction (AMI) in Veterans Health Administration (VHA) hospitals using individual-level data for costs and outcomes. DATA SOURCES: VHA administrative files for the fiscal years 2000–2006. STUDY DESIGN: Costs were defined as costs incurred during the index hospitalization for treatment of AMI. Mortality and readmission, assessed 1 year after the index hospitalization, were used as measures of clinical outcome. We examined health outcomes as a function of costs and other patient-level and hospital-level characteristics using a two-stage Cox proportional hazard model that accounted for competing risks within a multilevel framework. To control for patient comorbidities, we compiled a comprehensive list of comorbidities that have been found in other studies to affect mortality and readmissions. PRINCIPAL FINDINGS: We found that costs were negatively associated with mortality and readmissions. Every U.S.$100 less spent is associated with a 0.63 percent increase in the hazard of dying and a 1.24 percent increase in the hazard to be readmitted conditional on not dying. This main finding remained unchanged after a number of sensitivity checks. CONCLUSIONS: Our results suggest that there is a trade-off between costs and outcomes. The negative association between costs and mortality suggests that outcomes should be monitored closely when introducing cost-containment programs. Additional studies are needed to examine the cost–outcome relationship for conditions other than AMI to see whether our results are consistent. Blackwell Science Inc 2010-12 /pmc/articles/PMC2997322/ /pubmed/20819109 http://dx.doi.org/10.1111/j.1475-6773.2010.01161.x Text en © 2010 Health Research and Educational Trust
spellingShingle Quality of Care
Schreyögg, Jonas
Stargardt, Tom
The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title_full The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title_fullStr The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title_full_unstemmed The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title_short The Trade-Off between Costs and Outcomes: The Case of Acute Myocardial Infarction
title_sort trade-off between costs and outcomes: the case of acute myocardial infarction
topic Quality of Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997322/
https://www.ncbi.nlm.nih.gov/pubmed/20819109
http://dx.doi.org/10.1111/j.1475-6773.2010.01161.x
work_keys_str_mv AT schreyoggjonas thetradeoffbetweencostsandoutcomesthecaseofacutemyocardialinfarction
AT stargardttom thetradeoffbetweencostsandoutcomesthecaseofacutemyocardialinfarction
AT schreyoggjonas tradeoffbetweencostsandoutcomesthecaseofacutemyocardialinfarction
AT stargardttom tradeoffbetweencostsandoutcomesthecaseofacutemyocardialinfarction